During the past decade, Blekinge Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Blekinge Hospital" #1 sponsor was "Karolinska Institutet" with 5 trials, followed by "Stockholm South General Hospital" with 2 trials sponsored, "Uppsala University" with 2 trials sponsored, "Vastra Gotaland Region" with 2 trials sponsored and "AbbVie" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Blekinge Hospital" #1 collaborator was "The Swedish Research Council" with 3 trials as a collaborator, "Uppsala University" with 3 trials as a collaborator, "Blekinge County Council Hospital" with 2 trials as a collaborator, "Gothia Forum - Center for Clinical Trial" with 2 trials as a collaborator and "Anagnostics Bioanalysis GmbH" with 1 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Blekinge Hospital" are "Breast Cancer" (2 trials), "Myocardial Infarction" (2 trials), "ARDS, Human" (1 trials), "Acute Coronary Syndrome" (1 trials) and "Acute Myocardial Infarction" (1 trials). Many other conditions were trialed in "Blekinge Hospital" in a lesser frequency.

Most popular intervention types in "Blekinge Hospital" are "Drug" (7 trials), "Other" (5 trials), "Procedure" (4 trials), "Device" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "ASA 75-160 mg daily" (1 trials), "Adalimumab" (1 trials), "Added exercise" (1 trials) and "Anterior PROLIFT" (1 trials). Other intervention names were less common.

The vast majority of trials in "Blekinge Hospital" are 18 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Blekinge Hospital". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Blekinge Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Blekinge Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 7 trials that are defined as “Not Applicable".